AI가 선별한 이번 주 29개 전문과의 주요 논문
마지막 업데이트: 2026년 5월 11일
발표일: 2026-12-31
Gut microbes
MediLens 수록일: 2026-05-11
The study investigates the impact of obesity on circadian inflammatory rhythms, a key aspect of metabolic syndrome. It demonstrates that a high-fat diet disrupts microbiota-regulated glutathione metabolism, leading to altered colonic inflammatory rhythms. The use of fructo-oligosaccharide (FOS) a...
PubMed에서 읽기발표일: 2026-12-01
Annals of medicine
MediLens 수록일: 2026-05-12
This study validates the diagnostic accuracy of the endoscopic grading of gastric intestinal metaplasia (EGGIM) for identifying high-risk gastric intestinal metaplasia (GIM) patients. A total of 144 patients were evaluated, revealing an area under the curve (AUC) of 0.885 for EGGIM in diagnosing ...
PubMed에서 읽기발표일: 2026-05-11
Annals of surgical oncology
MediLens 수록일: 2026-05-12
This study evaluates the prognostic value of significant intra-pancreatic fat deposition (IPFD) in patients with high-grade pancreatic neuroendocrine neoplasms (panNENs). Among 87 patients, 27.6% exhibited significant IPFD, which was linked to worse overall and disease-specific survival outcomes....
PubMed에서 읽기발표일: 2026-05-11
Inflammatory bowel diseases
MediLens 수록일: 2026-05-12
This systematic review evaluated the efficacy of advanced therapies for treating extraintestinal manifestations (EIMs) in inflammatory bowel diseases (IBDs). It included 49 studies, revealing that TNF antagonists and JAK inhibitors were effective for musculoskeletal EIMs, with response rates of 6...
PubMed에서 읽기발표일: 2026-05-11
Acta oncologica (Stockholm, Sweden)
MediLens 수록일: 2026-05-12
This study investigates the effectiveness of pembrolizumab in treating advanced squamous cell carcinoma of the anal canal (SCCA) in a real-world cohort of 37 Danish patients. The objective response rate was 13.5%, with a clinical benefit rate of 48.6%. Median progression-free survival was 4.0 mon...
PubMed에서 읽기